Literature DB >> 8347380

Thiamin-responsive maple syrup urine disease in a patient antigenically missing dihydrolipoamide acyltransferase.

N P Ellerine1, W J Herring, L J Elsas, M C McKean, P D Klein, D J Danner.   

Abstract

Maple syrup urine disease results from inherited defects in human nuclear genes for branched chain alpha-ketoacid dehydrogenase, a mitochondrial multienzyme complex. Thiamin pyrophosphate is necessary for complex activity and a thiamin-responsive form of maple syrup urine disease is known. Here we demonstrate the use of [1-13C]leucine oxidation to [13C]O2 quantified in breath samples as a means of assessing whole body leucine oxidation. Analysis of cultured cells from this patient shows the antigenic lack of the E2 subunit, yet she gained branched chain alpha-ketoacid dehydrogenase activity in response to diet supplementation with pharmacologic doses of thiamin. These cultured cells were used to seek a molecular basis for the observed thiamin response. Despite normal thiamin transport in these cells, medium supplementation of up to 1000 thiamin/liter failed to increase complex activity or cause the antigenic appearance of the missing protein. This lack of response in cultured cells suggests that the observed whole body response to thiamin must be a tissue-specific effect in liver, muscle, or kidney. In addition, allele-specific detection of paternal and maternal mutations was used to genotype family members in this pedigree.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8347380     DOI: 10.1006/bmmb.1993.1037

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  5 in total

Review 1.  Uses of stable isotopes in clinical diagnosis and research in the paediatric population.

Authors:  O A Bodamer; D Halliday
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

Review 2.  Maple syrup urine disease 1954 to 1993.

Authors:  F Peinemann; D J Danner
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.

Authors:  J L Chuang; R P Cox; D T Chuang
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

4.  Gene preference in maple syrup urine disease.

Authors:  M M Nellis; D J Danner
Journal:  Am J Hum Genet       Date:  2000-12-07       Impact factor: 11.025

5.  Thiamine pyrophosphokinase deficiency causes a Leigh Disease like phenotype in a sibling pair: identification through whole exome sequencing and management strategies.

Authors:  Jamie L Fraser; Adeline Vanderver; Sandra Yang; Taeun Chang; Laura Cramp; Gilbert Vezina; Uta Lichter-Konecki; Kristina P Cusmano-Ozog; Patroula Smpokou; Kimberly A Chapman; Dina J Zand
Journal:  Mol Genet Metab Rep       Date:  2014-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.